At $4k for 145kt, revenue of US $580M is better than a poke in the eye with a blunt stick, which is what many of the wannabe producers are getting.
So applying an exchange rate of 0.68 (currently less) PLS has revenue of $850M for the quarter. That should take cash in bank to well over $3B.
Extrapolate for the next few years, add in the growth profile to 1Mt’s with downstream participation and you can see why those who purchased years ago are sitting pretty and don’t give a shite about PE ratios being assigned by the market price. In fact, many here are using this undervalued opportunity, to use the recent dividend payment to buy more.
PLS has a cash problem. How to spend it wisely.
Spodumene Prices, page-3200
-
- There are more pages in this discussion • 1,673 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PLS (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$2.89 |
Change
0.040(1.40%) |
Mkt cap ! $8.703B | |||
| Open | High | Low | Value | Volume |
| $2.78 | $2.89 | $2.78 | $29.90M | 10.51M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 39193 | $2.88 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $2.89 | 73947 | 7 |
View Market Depth
| Last trade - 16.10pm 01/11/2024 (20 minute delay) ? |
| PLS (ASX) Chart |